Patent · US Expired

1, 2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agents

US5635506A · kind A · utility

18Cited by
4References
83Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 1993
Grant dateJun 3, 1997
Priority date
Expiry dateNov 18, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to a compound useful for the treatment of tumors having the formula: ##STR1##

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.